ROS activates the cancer cell survival signal cascade, involving MAPK/ERK1/2, p38, JNK, and PI3K/Akt to activate NF-κB, matrix metalloproteinases, and VEGF to initiate cancer angiogenesis, metastasis, and survival [16]. Here, MAPK3 is linked to cancer.